Pre-filled Syringes: Market Size & Forecast 2026

The global pre-filled syringes (PFS) market reached approximately USD 11.5 billion in 2025, anchored by structurally resilient demand from biologics, vaccines, and chronic-disease injectables. Growth of roughly 8.5% annually through 2032 reflects the continued shift from vial-based to integrated drug-delivery formats, a conversion that carries both cost and compliance advantages for pharmaceutical manufacturers. Glass syringes command 65% of the installed base; cyclic olefin polymer (COP/COC) alternatives hold 25% and are gaining on breakage resistance and logistics economics. The supplier landscape is concentrated, top-4 operators account for an estimated 55-65% of global capacity, and qualification timelines of 18 to 36 months for new drug-device combinations create meaningful switching friction for buyers. Three structural forces are reshaping procurement economics. First, the EU Pack

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.